MedPath

efficacy of an online intervention including a smartphone application for participants with depressive symptoms

Not Applicable
Conditions
F32
Depressive episode
Registration Number
DRKS00011045
Lead Sponsor
AG Klinische Neuropsychologie, Klinik für Psychiatrie und Psychotherapie Universitätsklinikum Hamburg-Eppendorf
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
136
Inclusion Criteria

informed consent
depressive symptoms (PHQ-9>4)
access to a PC with internet access
access to a smartphone (iphone 5 or newer/Android 4.1 or newer)

Exclusion Criteria

no depressive symptoms (PHQ-9<5)
acute suicidal tendencies
bipolar disorder
schizophrenia/psychosis/other disorders from the schizophrenia spectrum
neurological illness or dementia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the reduction of depression symptom severity at post assessment (controlled for pre assessment scores), comparing the experimental and control group. For this purpose, participants complete the Patient Health Questionnaire (PHQ-9) at two times of measurement (pre - post, 4 weeks apart).
Secondary Outcome Measures
NameTimeMethod
WHO-Quality of Life BREF (WHO-QOL-BREF);<br>Behavioral Activation Depression Scale (BADS);<br>Dysfunctional Attitudes Scale (DAS-18B). Attitudes towards Psychological Online Interventions (APOI). All of the above mentioned questionnares are presented pre and post intervention.<br><br>only pre intervention: <br>sociodemographics, status of therapy (psychotherapy, medication, etc.)<br><br>only post:<br>Questionnaire capturing patients satisfaction (ZUF-8)<br>Questionnaire on side effects of the intervention (INEP-on)
© Copyright 2025. All Rights Reserved by MedPath